• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13D/A filed by Greenbrook TMS Inc. (Amendment)

    2/28/24 3:26:24 PM ET
    $GBNH
    Misc Health and Biotechnology Services
    Health Care
    Get the next $GBNH alert in real time by email
    SC 13D/A 1 d10991454_13d-a.htm

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, DC 20549

     

    SCHEDULE 13D

    THE SECURITIES EXCHANGE ACT OF 1934

    (Amendment No. 3)*

     

     

    Greenbrook TMS Inc.
    (Name of Issuer)

     

     

    Common Shares
    (Title of Class of Securities)

     

     

    393704309
    (CUSIP Number)

     

    Masters Special Situations, LLC

    3060 Peachtree Road, NW, Suite 1425

    Atlanta, Georgia 30305

    Telephone- (404) 364-2021

    (Name, Address and Telephone Number of Person Authorized to Receive

    Notices and Communications)

     

    February 26, 2024
    (Date of Event Which Requires Filing of this Statement)

     

    If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of ss.240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box [  ].
     
    Note:  Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits.  See § 240.13d-7 for other parties to whom copies are to be sent.

     

    ________________

    * The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

     

     

     

     

     

     

     

     

    The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     

     

    CUSIP No. 393704309    

     

    1. NAME OF REPORTING PERSONS  
      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)  
         
      MSS GB SPV LP  

     

    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
        (a)   [_]
        (b)   [x]

     

    3. SEC USE ONLY  
         

     

    4. SOURCE OF FUNDS  
         
      WC  

     

    5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)   [_]
         

     

    6. CITIZENSHIP OR PLACE OF ORGANIZATION  
         
      Delaware  

     

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

     

    7. SOLE VOTING POWER  
         
      0  

     

    8. SHARED VOTING POWER  
         
      899,997  

     

    9. SOLE DISPOSITIVE POWER
         
      0  

     

    10. SHARES DISPOSITIVE POWER   [_]
         
      899,997  

     

    11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING  
      PERSON  
         
      899,997  

     

    12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES  
      CERTAIN SHARES*  
         

     

    13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
      1.97%  

     

    14. TYPE OF REPORTING PERSON  
         
      PN  

     

     

     

    CUSIP No. 393704309    

     

    1. NAME OF REPORTING PERSONS  
      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)  
         
      Masters Special Situations, LLC  

     

    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
        (a)   [_]
        (b)   [x]

     

    3. SEC USE ONLY  
         

     

    4. SOURCE OF FUNDS  
         
      AF, WC  

     

    5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)   [_]
         

     

    6. CITIZENSHIP OR PLACE OF ORGANIZATION  
         
      Georgia  

     

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
         

     

    7. SOLE VOTING POWER  
         
      0  

     

    8. SHARED VOTING POWER  
         
      899,997  

     

    9. SOLE DISPOSITIVE POWER
         
      0  

     

    10. SHARES DISPOSITIVE POWER   [_]
         
      899,997  

     

    11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING  
      PERSON  
         
      899,997  

     

    12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES  
      CERTAIN SHARES*  
         

     

    13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
      1.97%  

     

    14. TYPE OF REPORTING PERSON  
         
      IA, OO  

     

     

    CUSIP No. 393704309    

     

    1. NAME OF REPORTING PERSONS  
      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)  
         
      MSS GB SPV LP  

     

    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
        (a)   [_]
        (b)   [x]

     

    3. SEC USE ONLY  
         

     

    4. SOURCE OF FUNDS  
         
      WC  

     

    5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)   [_]
         

     

    6. CITIZENSHIP OR PLACE OF ORGANIZATION  
         
      Delaware  

     

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH

     

    7. SOLE VOTING POWER  
         
      0  

     

    8. SHARED VOTING POWER  
         
      899,997  

     

    9. SOLE DISPOSITIVE POWER
         
      0  

     

    10. SHARES DISPOSITIVE POWER   [_]
         
      899,997  

     

    11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING  
      PERSON  
         
      899,997  

     

    12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES  
      CERTAIN SHARES*  
         

     

    13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
      1.97%  

     

    14. TYPE OF REPORTING PERSON  
         
      PN  

     

     

    CUSIP No. 393704309    

     

    1. NAME OF REPORTING PERSONS  
      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)  
         
      MSS GB SPV GP, LLC  

     

    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
        (a)   [_]
        (b)   [x]

     

    3. SEC USE ONLY  
         
         

     

    4. SOURCE OF FUNDS  
         
      AF, WC  

     

    5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)   [_]
         

     

    6. CITIZENSHIP OR PLACE OF ORGANIZATION  
         
      Delaware  

     

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
         

     

    7. SOLE VOTING POWER  
         
      0  

     

    8. SHARED VOTING POWER  
         
      899,997  

     

    9. SOLE DISPOSITIVE POWER
         
      0  

     

    10. SHARES DISPOSITIVE POWER   [_]
         
      899,997  

     

    11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING  
      PERSON  
     

     

    899,997

     

     

    12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES  
      CERTAIN SHARES*  
         

     

    13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
      1.97%  

     

    14. TYPE OF REPORTING PERSON  
         
      OO  

     

     

    CUSIP No. 393704309    

     

    1. NAME OF REPORTING PERSONS  
      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)  
         
      Masters Capital Management, LLC  

     

    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
        (a)   [_]
        (b)   [x]

     

    3. SEC USE ONLY  
         

     

    4. SOURCE OF FUNDS  
         
      AF, WC  

     

    5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)   [_]
         

     

    6. CITIZENSHIP OR PLACE OF ORGANIZATION  
         
      Georgia  

     

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
         

     

    7. SOLE VOTING POWER  
         
      0  

     

    8. SHARED VOTING POWER  
         
      3,427,272  

     

    9. SOLE DISPOSITIVE POWER
         
      0  

     

    10. SHARES DISPOSITIVE POWER   [_]
         
      3,427,272  

     

    11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING  
      PERSON  
         
      3,427,272  

     

    12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES  
      CERTAIN SHARES*  
         

     

    13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
      7.52%  

     

    14. TYPE OF REPORTING PERSON  
         
      IA, OO  

     

     

    CUSIP No. 393704309    

     

    1. NAME OF REPORTING PERSONS  
      I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)  
         
      Michael Masters  

     

    2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
        (a)   [_]
        (b)   [x]

     

    3. SEC USE ONLY  
         

     

    4. SOURCE OF FUNDS  
         
      AF, WC  

     

    5. CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e)   [_]
         

     

    6. CITIZENSHIP OR PLACE OF ORGANIZATION  
         
      United States of America  

     

    NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH
         

     

    7. SOLE VOTING POWER  
         
      0  

     

    8. SHARED VOTING POWER  
         
      4,327,269  

     

    9. SOLE DISPOSITIVE POWER
         
      0  

     

    10. SHARES DISPOSITIVE POWER   [_]
         
      4,327,269  

     

    11. AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING  
      PERSON  
     

     

    4,327,269

     

     

    12. CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES  
      CERTAIN SHARES*  
         

     

    13. PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)  
         
      9.49%  

     

    14. TYPE OF REPORTING PERSON  
         
      IN, HC  

     

     

    CUSIP No. 393704309    

     

    Item 1. Security and Issuer.  

     

      This statement on Schedule 13D (the “Schedule 13D”) relates to the Common Shares of Greenbrook TMS Inc., an Ontario corporation with its principal executive offices located at 890 Yonge Street, 7th Floor, Toronto, Ontario, Canada M4W 3P4 (the “Issuer”).  
         

     

    Item 2. Identity and Background.  

     

      (a)-(c), (f)

    This Schedule 13D amendment is being filed jointly by (i) Masters Special Situations, LLC, a Georgia limited liability company, (ii) MSS GB SPV LP, a Delaware limited partnership, (iii) MSS GB SPV GP, LLC, a Delaware limited liability company, (iv) Masters Capital Management, LLC, a Georgia limited liability company and (v) Michael Masters, a United States citizen (collectively, the “Reporting Persons”).

     

    The principal business address of the Reporting Persons is 3060 Peachtree Road, NW, Suite 1425, Atlanta, Georgia 30305.

     

    Michael Masters is the controlling founder of Masters Special Situations, LLC and Masters Capital Management, LLC, each an investment management firm that serves as the investment manager to certain private funds, including MSS GB SPV LP. MSS GB SPV GP, LLC serves as the general partner of MSS GB SPV LP.

     

     

      (d)

    None of the Reporting Persons has, during the last five years, been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors).

     

     
      (e)

    None of the Reporting Persons has, during the last five years, been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or state securities laws or finding any violation with respect to such laws.

     

     

    Item 3. Source and Amount of Funds or Other Consideration.  

     

     

    The funds for the purchase of the Common Shares beneficially owned by the Reporting Persons came from the working capital of MSS GB SPV LP and the private funds managed by Masters Capital Management, LLC.

     

    No borrowed funds were used to purchase the Shares, other than any borrowed funds used for working capital purposes (including certain leverage arrangements) in the ordinary course of business.

     

     

    Item 4. Purpose of Transaction.  

     

     

    The Common Shares held by the Reporting Persons were acquired for investment purposes in the ordinary course of the Reporting Persons’ investment activities.

     

    Except as otherwise set forth herein, the Reporting Persons do not have any present plans or proposals which would relate to, or result in, the matters set forth in subparagraphs (a) – (j) of Item 4 of Schedule 13D.

     

    The Reporting Persons reserve the right, at a later date, to effect one or more of such changes or transactions in the number of Shares they may be deemed to beneficially own.

     
         

     

     

     

    Item 5. Interest in Securities of the Issuer.  

     

     

    (a)-(c)

     

     

    As of the date hereof, (i) Michael Masters may be deemed to be the beneficial owner of 4,327,269 Common Shares or 9.49% of the Common Shares of the Issuer, (ii) Masters Capital Management, LLC may be deemed to be the beneficial owner of 3,427,272 Common Shares or 7.52% of the Common Shares of the Issuer, and (iii) each of MSS GB SPV LP, MSS GB SPV GP, LLC and Masters Special Situations, LLC may be deemed to be the beneficial owner of 899,997 Common Shares or 1.97% of the Common Shares of the Issuer, in each case based upon 45,602,260 Common Shares outstanding as of February 26, 2024 according to the Issuer.

     

    Michael Masters has the sole power to vote or direct the vote of 0 Common Shares and the shared power to vote or direct the vote of 4,327,269 Common Shares.

     

    Masters Capital Management, LLC has the sole power to vote or direct the vote of 0 Common Shares and the shared power to vote or direct the vote of 3,427,272 Common Shares.

     

    Each of MSS GB SPV LP, MSS GB SPV GP, LLC and Masters Special Situations, LLC has the sole power to vote or direct the vote of 0 Common Shares and the shared power to vote or direct the vote of 899,997 Common Shares.

     

    Michael Masters has the sole power to dispose or direct the disposition of 0 shares of Common Shares and the shared power to dispose or direct the disposition of 4,327,269 Common Shares

     

    Masters Capital Management, LLC has the sole power to dispose or direct the disposition of 0 shares of Common Shares and the shared power to dispose or direct the disposition of 3,427,272 Common Shares.

     

    Each of MSS GB SPV LP, MSS GB SPV GP, LLC and Masters Special Situations, LLC has the sole power to dispose or direct the disposition of 0 shares of Common Shares and the shared power to dispose or direct the disposition of 899,997 Common Shares.

     

    There have been no transactions by the Reporting Persons in the Common Shares during the past sixty days.

     

    The aforementioned Common Shares were acquired for investment purposes. The Reporting Persons may acquire additional securities of the Issuer, dispose of all or some of these securities from time to time, in each case in open market or private transactions, block sales or purchases or otherwise, or may continue to hold the Common Shares.

     

    The Reporting Persons specifically disclaim beneficial ownership in the Common Shares reported herein except to the extent of their pecuniary interest therein.

     

     

    Item 6. Contracts, Arrangements, Understandings or Relationships with Respect  
      to Securities of the Issuer.  

     

      This Item is not applicable.  
         

     

    Item 7. Material to be Filed as Exhibits.  

     

      An agreement relating to the filing of a joint statement as required by Rule 13d-1(f) under the Securities Exchange Act of 1934 is filed herewith as Exhibit A.  
         

     

     

     

    SIGNATURE

     

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     

      February 28, 2024
      (Date)

     

     

    MASTERS SPECIAL SITUATIONS, LLC

    By: /s/ Michael Masters

            Michael Masters, Authorized Signatory

     

    MSS GB SPV LP

    By: MSS GB SPV GP, LLC

    By: Masters Special Situations, LLC

    By: /s/ Michael Masters

            Michael Masters, Authorized Signatory

     

    MSS GB SPV GP, LLC

    By: Masters Special Situations, LLC

    By: /s/ Michael Masters

            Michael Masters, Authorized Signatory

     

    MASTERS CAPITAL MANAGEMENT, LLC

    By: /s/ Michael Masters

       Michael Masters, Managing Member

     

    MICHAEL MASTERS

            /s/ Michael Masters

     

     

     

    Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001).

     

     

     

    Exhibit A

     

    AGREEMENT

     

    The undersigned agree that this Amendment No. 3 to Schedule 13D, dated February 28, 2024, relating to the Common Shares of Greenbrook TMS Inc. shall be filed on behalf of the undersigned.

     

    February 28, 2024  
    (Date)  

     

    Masters SPECIAL SITUATIONS, LLC

    By: /s/ Michael Masters

           Michael Masters, Authorized Signatory

     

    MSS GB SPV LP

    By: MSS GB SPV GP, LLC

    By: Masters Special Situations, LLC

    By: /s/ Michael Masters

           Michael Masters, Authorized Signatory

     

    MSS GB SPV GP, LLC

    By: Masters Special Situations, LLC

    By: /s/ Michael Masters

           Michael Masters, Authorized Signatory

     

    Masters CAPITAL MANAGEMENT, LLC

    By: /s/ Michael Masters

           Michael Masters, Managing Member

     

    MICHAEL MASTERS

           /s/ Michael Masters

     

     

     

    Get the next $GBNH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $GBNH

    DatePrice TargetRatingAnalyst
    More analyst ratings

    $GBNH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Greybrook Announces Passing of Founder Elias Vamvakas

      TORONTO, July 11, 2024 /CNW/ - It is with heavy hearts that the Executive Team at Greybrook announces the passing of our cherished founder, Elias Vamvakas, today, after a courageous battle with pancreatic cancer. Elias was 65 years old. Elias Vamvakas was a visionary leader whose entrepreneurial spirit and dedication laid the foundation for Greybrook, a distinguished Canadian private equity firm with investments in real estate and health care. Born in 1958 in Athens, Greece, Elias immigrated to Canada in 1966. His journey from an immigrant to a celebrated business leader was a

      7/11/24 1:55:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS ANNOUNCES DELISTING FROM NASDAQ

      TORONTO, Feb. 23, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced receipt of the final delisting notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") due to the continued failure to satisfy either the $1.00 minimum bid price listing requirement in Nasdaq Listing Rule 5550(a)(2) or the minimum stockholders' equity requirements in Nasdaq Listing Rule 5550(b). Nasdaq has notified the Company that trading of its common shares (the "Common Shares") will be suspended as of the open of trading on February 26, 2024. After careful consideration, the Company determined that it was in the overall best interests

      2/23/24 9:00:00 AM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • Greenbrook Announces $1.2 Million Registered Direct Offering

      TORONTO, Feb. 22, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company"), today announced that it has entered into securities purchase agreements with  institutional investors for the purchase and sale of 6,000,000 common shares at a purchase price of $0.20 per share pursuant to a registered direct offering, resulting in gross proceeds of approximately $1.2 million before deducting placement agent commissions and other estimated offering expenses. The closing of the offering is expected to occur on or about February 26, 2024, subject to the satisfaction of customary closing conditions. The Company intends to use the net proceeds for working capital as well as

      2/22/24 8:00:00 AM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care

    $GBNH
    Financials

    Live finance-specific insights

    See more
    • GREENBROOK TMS ANNOUNCES DELISTING FROM NASDAQ

      TORONTO, Feb. 23, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced receipt of the final delisting notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC ("Nasdaq") due to the continued failure to satisfy either the $1.00 minimum bid price listing requirement in Nasdaq Listing Rule 5550(a)(2) or the minimum stockholders' equity requirements in Nasdaq Listing Rule 5550(b). Nasdaq has notified the Company that trading of its common shares (the "Common Shares") will be suspended as of the open of trading on February 26, 2024. After careful consideration, the Company determined that it was in the overall best interests

      2/23/24 9:00:00 AM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS RAISES US$2.5 MILLION IN DEBT FINANCING

      TORONTO, Feb. 15, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twenty-fifth amendment (the "Amendment") to the Company's credit facility (the "Credit Facility") with affiliates of Madryn Asset Management, LP ("Madryn"). As part of the Amendment, the Company secured an additional US$2,538,071 in senior secured term loans from Madryn under the Credit Facility (the "New Loan"). After giving effect to the New Loan, the Company has an aggregate amount of approximately US$87 million outstanding under the Credit Facility. The proceeds of the New Loan are expected to be used by the Company for general corporate an

      2/15/24 5:21:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS RAISES US$1.5 MILLION IN DEBT FINANCING

      TORONTO, Feb. 6, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it has entered into the twenty-fourth amendment (the "Amendment") to the Company's credit facility (the "Credit Facility") with affiliates of Madryn Asset Management, LP ("Madryn"). As part of the Amendment, the Company secured an additional US$1,522,843 in senior secured term loans from Madryn under the Credit Facility (the "New Loan"). After giving effect to the New Loan, the Company has an aggregate amount of approximately US$85 million outstanding under the Credit Facility. The proceeds of the New Loan are expected to be used by the Company for general corporate an

      2/6/24 5:15:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care

    $GBNH
    SEC Filings

    See more
    • Greenbrook TMS Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

      8-K - Greenbrook TMS Inc. (0001735948) (Filer)

      3/15/24 3:46:21 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • Greenbrook TMS Inc. filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Greenbrook TMS Inc. (0001735948) (Filer)

      3/8/24 3:19:54 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • Greenbrook TMS Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

      8-K - Greenbrook TMS Inc. (0001735948) (Filer)

      3/1/24 4:58:50 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care

    $GBNH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Greenbrook TMS Inc. (Amendment)

      SC 13D/A - Greenbrook TMS Inc. (0001735948) (Subject)

      2/28/24 5:22:33 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13D/A filed by Greenbrook TMS Inc. (Amendment)

      SC 13D/A - Greenbrook TMS Inc. (0001735948) (Subject)

      2/28/24 3:26:24 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form SC 13D/A filed by Greenbrook TMS Inc. (Amendment)

      SC 13D/A - Greenbrook TMS Inc. (0001735948) (Subject)

      10/24/23 4:15:27 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care

    $GBNH
    Leadership Updates

    Live Leadership Updates

    See more
    • GREENBROOK APPOINTS PETER WILLETT AS CHIEF FINANCIAL OFFICER

      TORONTO, Jan. 29, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that the Company's Board of Directors has appointed Mr. Peter Willett as the Company's full-time Chief Financial Officer, effective immediately. Mr. Willett was appointed Interim Chief Financial Officer of the Company in October 2023, prior to which he has been a key player on the Greenbrook finance team over the past six years, serving as its Senior Vice President of Finance. Peter brings over 11 years of finance experience, providing a broad base of experience and specialized knowledge about the financial and accounting matters that are unique to the mental health servic

      1/29/24 5:00:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS ANNOUNCES DIRECTOR APPOINTMENT

      TORONTO, Jan. 23, 2024 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company") today announced that it has appointed Ms. Juliana Elstad to the Company's board of directors as an independent director, effective immediately. Ms. Elstad has also been appointed to the Company's Governance and Nominating Committee. Juliana Elstad is a CEO, entrepreneur, and advisor with over 20 years of experience bringing medical innovation to patients and delivering success in small startup to multi-billion-dollar environments. She has a proven track record of creating, growing, and leading medical technology organizations with a focus on building dynamic cultures and mentoring high-po

      1/23/24 4:31:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • GREENBROOK TMS ANNOUNCES RESULTS OF VOTING AT ANNUAL MEETING OF SHAREHOLDERS

      TORONTO, June 20, 2023 /PRNewswire/ - Greenbrook TMS Inc. (NASDAQ:GBNH) ("Greenbrook" or the "Company"), a leading provider of Transcranial Magnetic Stimulation ("TMS") therapy in the United States, announced today the results of voting at its annual meeting of shareholders held earlier today (the "Meeting"). Each of the matters voted upon at the Meeting as set out below is described in greater detail in the Notice of Annual Meeting of Shareholders and Management Information Circular of Greenbrook dated May 11, 2023 (the "Circular").   The total number of common shares represented at the Meeting was 29,769,721, representing approximately 72.96% of Greenbrook's outstanding common shares entit

      6/20/23 5:00:00 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care

    $GBNH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 3 filed by new insider Crish Andrew

      3 - Greenbrook TMS Inc. (0001735948) (Issuer)

      3/8/24 4:51:46 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • SEC Form 3 filed by new insider Elstad Juliana

      3 - Greenbrook TMS Inc. (0001735948) (Issuer)

      2/2/24 4:31:30 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care
    • New insider Madryn Asset Management, Lp claimed ownership of 6,363,636 shares (SEC Form 3)

      3 - Greenbrook TMS Inc. (0001735948) (Issuer)

      1/11/24 9:45:02 PM ET
      $GBNH
      Misc Health and Biotechnology Services
      Health Care